Login
Home / TWAPF : OTC
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis News Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Towa Pharmaceutical Co., Ltd.

$25.98 +$9.15 (+54.37%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$25.98
Day Range
$25.98$26
Year Range
$16.83$26
Market Cap
1.28B
AVG Volume
4
Trailing/Forward PE
21.05/0.05
PEG ratio
-48.08
Dividend Yield
2.26%
Next Earnings Date
2026-11-16
Primary Exchange
Other OTCUS
Revenue (JPY)
020B40B60B80B24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
Net Income (JPY)
-20B-10B010B24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
Operating Income (JPY)
02.5B5B7.5B10B24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
EBITDA (JPY)
05B10B15B24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
Cash Flows (JPY)
-20B-10B010B20B24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
EPS (JPY)
-400-200020024 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
Expenses (JPY)
010B20B30BR&DSG&ACapex24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
Cash & Debt (JPY)
0100B200B300BCashLong Term DebtShort Term Debt24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
Debt ratios
024624 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
Margins
0%10%20%30%40%24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
Return on Capital
-10%-5%0%5%24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
Shares Outstanding
020M40M60M24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
Dividends (JPY)
00.10.20.3Sep 22Mar 23Sep 23Mar 24Sep 24Mar 25Sep 25Mar 26Sep 26Mar 27
Book Value Per Share (JPY)
0100020003000400024 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
Total Assets (JPY)
0200B400B600B24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
PE Ratio
010203040med 6.47Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Free Cash Flow Yield
-15%-10%-5%0%5%10%med 2.65%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Price to Sales
0.40.50.60.70.80.9med 0.49Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
EV/EBITDA
681012med 7.25Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Price/Operating Cashflow
0510152025med 5.69Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Price to Book
0.60.811.2med 0.73Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Towa Pharmaceutical Co., Ltd.
TWAPF
Stockpicker

Video analysis: TWAPF

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: TWAPF

Financial Contrast: Towa Pharmaceutical (OTCMKTS:TWAPF) vs. Crinetics Pharmaceuticals (NASDAQ:CRNX)

defenseworld.net · 17 Aug 2026

Financial Contrast: Towa Pharmaceutical (OTCMKTS:TWAPF) vs. Crinetics Pharmaceuticals (NASDAQ:CRNX)

Crinetics Pharmaceuticals (NASDAQ: CRNX - Get Free Report) and Towa Pharmaceutical (OTCMKTS:TWAPF - Get Free Report) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their risk, profitability, earnings, dividends, analyst recommendations, valuation and institutional ownership. Profitability This table compares Crinetics Pharmaceuticals and Towa

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.